Skip to main content

Table 2 Association of CETRUS scores with the clinicopathologic characteristics of 77 patients with localized prostate cancer who underwent radical prostatectomy

From: Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer

Variables

No.

Low score (score ≤ 3)

High score (score > 3)

p

Age (years)

0.834

  ≤ 65

43

20 (46.5%)

23 (53.5%)

 

  > 65

34

15 (44.1%)

19 (55.9%)

 

Tumor stage

0.756

 T1N0M0

25

12 (48.0%)

13 (52.0%)

 

 T2N0M0

52

23 (44.2%)

29 (55.8%)

 

Gleason score

0.291

  ≤ 7

51

21 (41.2%)

30 (58.8%)

 

  > 7

26

14 (53.8%)

12 (46.2%)

 

PSA (ng/mL)

0.611

  < 15

46

22 (47.8%)

24 (52.2%)

 

  ≥ 15

31

13 (41.9%)

18 (58.1%)

 

BMI (kg/m2)

0.802

  < 25

43

19 (44.2%)

24 (55.8%)

 

  ≥ 25

34

16 (47.1%)

18 (52.9%)

 

ECOG PS

0.567

 0

51

22 (43.1%)

29 (56.9%)

 

  ≥ 1

26

13 (50.0%)

13 (50.0%)

 

 Total

77

35 (45.5%)

42 (54.5%)

Â